secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMICUS THERAPEUTICS, INC. (—)
CIK:        0001178879
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001104659-23-093669
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amicus Therapeutics Appoints Simon Harford as CFO; Daphne Quimi to Retire by Year End
--------------------------------------------------------------------------------

- Simon Harford appointed CFO effective August 21, 2023; replaces Daphne Quimi who will retire at year end.
- Harford receives base salary $500,000, bonus target 45% of salary, and initial equity award valued at $2.7M.
- Company reiterates expectation to achieve profitability in second half of 2023.
- Harford previously served as CFO of Albireo Pharma and Parexel; 30+ years healthcare finance experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178879/000110465923093669/0001104659-23-093669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178879/000110465923093669/tm2324228d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-093669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer